Sebastian Haeusner
Papers
1
Total Citations
13
H-Index
1
About
Dr. Sebastian Haeusner is a leading figure in the translation of regenerative medicine from the lab bench to the clinic, with a primary focus on the scalable manufacturing of Advanced Therapy Medicinal Products (ATMPs). His most impactful work, "From Single Batch to Mass Production–Automated Platform Design Concept for a Phase II Clinical Trial Tissue Engineered Cartilage Product" (2021, 13 citations), addresses the critical bottleneck in the field: transitioning from manual, small-scale production to automated, compliant manufacturing for late-stage clinical trials. This contribution is pivotal for making tissue-engineered products, particularly for cartilage repair, a viable therapeutic reality. Dr. Haeusner’s research bridges bioengineering, process automation, and regulatory science, directly tackling the challenges of reproducibility and quality control that have historically hindered ATMP commercialization. His work is essential reading for students and researchers interested in the industrialisation of cell-based therapies, demonstrating how thoughtful platform design can unlock the potential of living medicines for chronic diseases with no current cure.
Research Focus
Key Achievements
Top Papers
- 1